Cargando…
Serum neuron specific enolase (NSE) is a determinant of response duration in small cell lung cancer (SCLC).
Seventy-two consecutive patients were eligible for a study of clinical determinants of response and response duration in small cell lung cancer (SCLC). Pretreatment values of routine laboratory parameters, and three tumour markers: neuron specific enolase (NSE), carcinoembryonic antigen (CEA), and a...
Autores principales: | Jørgensen, L. G., Osterlind, K., Hansen, H. H., Cooper, E. H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977938/ https://www.ncbi.nlm.nih.gov/pubmed/1325829 |
Ejemplares similares
-
Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC).
por: Jørgensen, L. G., et al.
Publicado: (1994) -
Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres.
por: Jørgensen, L. G., et al.
Publicado: (1996) -
The prognostic influence of serum neuron specific enolase in small cell lung cancer.
por: Jørgensen, L. G., et al.
Publicado: (1988) -
Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres
Publicado: (1996) -
Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer.
por: Jørgensen, L. G., et al.
Publicado: (1991)